Related references
Note: Only part of the references are listed.Role of IgA receptors in the pathogenesis of IgA nephropathy
Sebastian M. Lechner et al.
JOURNAL OF NEPHROLOGY (2016)
Role of complement in IgA nephropathy
Mohamed R. Daha et al.
JOURNAL OF NEPHROLOGY (2016)
Current Understanding of the Role of Complement in IgA Nephropathy
Nicolas Maillard et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Identifying the ideal metric of proteinuria as a predictor of renal outcome in idiopathic glomerulonephritis
Sean J. Barbour et al.
KIDNEY INTERNATIONAL (2015)
Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes
Laureline Berthelot et al.
KIDNEY INTERNATIONAL (2015)
Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy
Junichi Yasutake et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Identification of new susceptibility loci for IgA nephropathy in Han Chinese
Ming Li et al.
NATURE COMMUNICATIONS (2015)
Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy
Nannan Wang et al.
PEERJ (2015)
Novel Biomarkers in Glomerular Disease
Yasar Caliskan et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2014)
Cytokines Alter IgA1 O- Glycosylation by Dysregulating C1GalT1 and ST6GalNAc-II Enzymes*
Hitoshi Suzuki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The Combined Role of Galactose-Deficient IgA1 and Streptococcal IgA-Binding M Protein in Inducing IL-6 and C3 Secretion from Human Mesangial Cells: Implications for IgA Nephropathy
Roland Schmitt et al.
JOURNAL OF IMMUNOLOGY (2014)
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments
Rosanna Coppo et al.
KIDNEY INTERNATIONAL (2014)
MiR-223 downregulation promotes glomerular endothelial cell activation by upregulating importin α4 and α5 in IgA nephropathy
Hao Bao et al.
KIDNEY INTERNATIONAL (2014)
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens
Krzysztof Kiryluk et al.
NATURE GENETICS (2014)
MicroRNAs in IgA nephropathy
Cheuk-Chun Szeto et al.
NATURE REVIEWS NEPHROLOGY (2014)
Changes in Nephritogenic Serum Galactose-Deficient IgA1 in IgA Nephropathy following Tonsillectomy and Steroid Therapy
Junichiro Nakata et al.
PLOS ONE (2014)
Prognosis in IgA Nephropathy: 30-Year Analysis of 1,012 Patients at a Single Center in Japan
Takahito Moriyama et al.
PLOS ONE (2014)
A Panel of Serum Biomarkers Differentiates IgA Nephropathy from Other Renal Diseases
Hiroyuki Yanagawa et al.
PLOS ONE (2014)
Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy
Yukihiro Wada et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2013)
Soluble transferrin receptor in urine, a new biomarker for IgA nephropathy and Henoch-Schonlein purpura nephritis
Sigurd E. Delanghe et al.
CLINICAL BIOCHEMISTRY (2013)
Association of Urinary Laminin G-Like 3 and Free K Light Chains with Disease Activity and Histological Injury in IgA Nephropathy
Maria Teresa Rocchetti et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Fluctuation of serum C3 levels reflects disease activity and metabolic background in patients with IgA nephropathy
Hiyori Suzuki et al.
JOURNAL OF NEPHROLOGY (2013)
IgA Nephropathy
Robert J. Wyatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Urinary Fractalkine and Monocyte Chemoattractant Protein-1 as Possible Predictors of Disease Activity of Childhood Glomerulonephritis
Tomomi Aizawa et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Risk Stratification of Patients With IgA Nephropathy
Sean J. Barbour et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy
L. -L. Liu et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Relationships between Levels of Urinary Podocalyxin, Number of Urinary Podocytes, and Histologic Injury in Adult Patients with IgA Nephropathy
Rin Asao et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Transglutaminase is essential for IgA nephropathy development acting through IgA receptors
Laureline Berthelot et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Abnormal miR-148b Expression Promotes Aberrant Glycosylation of IgA1 in IgA Nephropathy
Grazia Serino et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy
Francois Berthoux et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression
Na Zhao et al.
KIDNEY INTERNATIONAL (2012)
The retrospective analysis of 343 Czech patients with IgA nephropathy-one centre experience
Dita Maixnerova et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis
Krzysztof Kiryluk et al.
PLOS GENETICS (2012)
The Use of the Oxford Classification of IgA Nephropathy to Predict Renal Survival
Eric Alamartine et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Predicting the Risk for Dialysis or Death in IgA Nephropathy
Francois Berthoux et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
The Pathophysiology of IgA Nephropathy
Hitoshi Suzuki et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Genome-wide association study identifies susceptibility loci for IgA nephropathy
Ali G. Gharavi et al.
NATURE GENETICS (2011)
High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy
Hilde P. E. Peters et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells
Jan Novak et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort
Shubha S. Bellur et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Galactose-Deficient IgA1 in African Americans with IgA Nephropathy: Serum Levels and Heritability
M. Colleen Hastings et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy
Mai T. Vuong et al.
KIDNEY INTERNATIONAL (2010)
The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults
Rosanna Coppo et al.
KIDNEY INTERNATIONAL (2010)
Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
David M. Good et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Identification of a uromodulin fragment for diagnosis of IgA nephropathy
Jie Wu et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2010)
Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity
Hitoshi Suzuki et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility
Ian S. D. Roberts et al.
KIDNEY INTERNATIONAL (2009)
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification
Daniel C. Cattran et al.
KIDNEY INTERNATIONAL (2009)
The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy
D. D. Torres et al.
KIDNEY INTERNATIONAL (2008)
Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy
Sachiko Shimozato et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Inflammatory markers and the progression of IgA glomerulonephritis
Kati Kaartinen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Activation of podocytes by mesangial-derived TNF-α:: glomerulo-podocytic communication in IgA nephropathy
Kar Neng Lai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Remission of proteinuria improves prognosis in IgA nephropathy
Heather N. Reich et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels
Z. Moldoveanu et al.
KIDNEY INTERNATIONAL (2007)
Repetitive fragmentation products of albumin and α1-antitrypsin in glomerular diseases associated with nephrotic syndrome
Giovanni Candiano et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Fcα receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease):: Evidence for pathogenic soluble receptor-IgA complexes in patients and CD89 transgenic mice
P Launay et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
